EUCTR2010-019223-55-HU进行中（未招募）不适用
The Impact of LY2189265 versus Insulin Glargine Both in Combination with Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus - GBDD
Eli Lilly & Company0 个研究点目标入组 837 人开始时间: 2010年12月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 837
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •See protocol for details.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •See protocol for details.
研究者
相似试验
进行中（未招募）
不适用
A study in Type 2 Diabetes MellitusType 2 Diabetes MellitusEUCTR2010-019223-55-DKEli Lilly & Company925
进行中（未招募）
1 期
The Impact of LY2189265 versus Insulin Glargine Both in Combination with Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus(AWARD-4: Assessment of Weekly AdministRation of LY2189265 in Diabetes – 4) - GBDD(a)MedDRA version: 14.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2010-019223-55-BEEli Lilly & Company837
进行中（未招募）
不适用
The Impact of LY2189265 versus Insulin Glargine Both in Combination with Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus - GBDDMedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitusType 2 Diabetes MellitusEUCTR2010-019223-55-GREli Lilly & Company837
进行中（未招募）
不适用
A study in Type 2 Diabetes MellitusDiabetes Mellitus, type 2MedDRA version: 14.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2010-019223-55-SEEli Lilly & Company837
进行中（未招募）
不适用
A Study in Type 2 DiabetesType 2 Diabetes MellitusEUCTR2011-001254-29-ITELI LILLY1,325